Regis Lelou is Director, Commercial Development Bioconjugates at Lonza. He recently completed 20 years with the company. Over his tenure, he has held a wide range of roles across process development, technology transfer, validation, and GMP manufacturing support, giving him a deep, end‑to‑end understanding of integrated bioconjugate and ADC execution. He brings extensive hands‑on experience in the ADC space, combining strong technical execution with a customer‑focused mindset. In his current role, he is responsible for shaping innovative offerings for customers that embark on an integrated bioconjugate development journey.